GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mmp2 | increases activity | EXP | | 6480464 | CTD | Indomethacin results in increased activity of MMP2 protein | PMID:10878458 | Mmp2 | multiple interactions | EXP | | 6480464 | CTD | Indomethacin results in decreased expression of and results in decreased secretion of and results in decreased activity of MMP2 protein; Indomethacin results in decreased expression of and results in decreased secretion of MMP2 protein; Melatonin inhibits the reaction [Indomethacin results in decreased expression of and results in decreased secretion of and results in decreased activity of MMP2 protein]; Melatonin inhibits the reaction [Indomethacin results in decreased expression of and results in decreased secretion of MMP2 protein] | PMID:16150113 PMID:16934674 | Mmp2 | decreases activity | ISO | Mmp2 (Mus musculus) | 6480464 | CTD | Indomethacin results in decreased activity of MMP2 protein | PMID:16537180 | Mmp2 | multiple interactions | ISO | MMP2 (Homo sapiens) | 6480464 | CTD | Indomethacin results in decreased expression of and results in decreased activity of MMP2 protein | PMID:11719597 | Mmp2 | multiple interactions | ISO | Mmp2 (Mus musculus) | 6480464 | CTD | [BMP7 protein co-treated with INS1 protein co-treated with Triiodothyronine co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with Nicotine] affects the expression of MMP2 mRNA; [Indomethacin co-treated with Medroxyprogesterone Acetate] results in decreased activity of MMP2 protein | PMID:16537180 PMID:33091441 | |
Go Back to source page | Continue to Ontology report |